Jatana Vishal, Gillis Jonathan, Webster Boyd H, Adès Lesley C
Paediatric Intensive Care Unit, The Children's Hospital at Westmead, New South Wales, Australia.
Pediatr Crit Care Med. 2007 Sep;8(5):459-63; quiz 464. doi: 10.1097/01.pcc.0000290023.89437.58.
To report on the experience of a pediatric intensive care unit (PICU) with patients with deletion 22q11.2 syndrome: 1) to delineate the clinical characteristics and management of these patients; 2) to assess whether these patients were managed appropriately, especially in terms of blood transfusion; and 3) to make recommendations for PICU management.
Retrospective assessment of medical records of patients with fluorescent in situ hybridization-proven 22q11 deletion admitted to the PICU at the Children's Hospital at Westmead, Sydney.
PICU in a tertiary university-affiliated children's hospital.
Sixty-five consecutive admissions in 40 patients with diagnosis of 22q11 deletion over a 4-yr period.
None.
Thirty-seven (57%) of 65 admissions were postoperative cardiac surgical and accounted for the most common reason for admission to the PICU. Thirteen (20%) admissions were for velopharyngeal/laryngeal problems. Four (6%) admissions were associated with hypocalcemia, with two being first presentations. Five (12.5%) of 40 patients had immune dysfunction, one of whom developed cytomegalovirus pneumonitis. Twenty-nine (72.5%) patients received blood products either immediately before PICU admission or in the PICU. Of these, 16 received nonirradiated cellular blood products. There were two deaths from complications of congenital heart disease.
PICUs need to be familiar with deletion 22q11.2 syndrome, especially the recommended use of irradiated and cytomegalovirus-seronegative blood components in these immunocompromised patients. The guidelines were inconsistently followed in the cohort of patients reported here. The extent of this problem may be more widespread in PICUs, and we recommend that individual units review their practice in this regard. Hypocalcemia may manifest at any time, and a regular survey of the calcium status is required in the intensive care setting. Admission to PICU should afford the opportunity to invite subspecialty referral and optimize extended care.
报告一家儿科重症监护病房(PICU)对22q11.2缺失综合征患者的治疗经验:1)描述这些患者的临床特征及治疗方法;2)评估这些患者的治疗是否恰当,尤其是在输血方面;3)为PICU的治疗提出建议。
对悉尼韦斯特米德儿童医院PICU收治的经荧光原位杂交证实为22q11缺失的患者的病历进行回顾性评估。
一所大学附属三级儿童医院的PICU。
4年期间连续收治的40例诊断为22q11缺失的患者,共65人次。
无。
65人次入院中有37人次(57%)是心脏手术后入住,这是入住PICU最常见的原因。13人次(20%)入院是因为腭咽/喉部问题。4人次(6%)入院与低钙血症有关,其中2例是首次出现。40例患者中有5例(12.5%)存在免疫功能障碍,其中1例发生巨细胞病毒性肺炎。29例(72.5%)患者在入住PICU前或在PICU期间接受了血液制品。其中,16例接受了未经辐照的细胞血液制品。有2例死于先天性心脏病并发症。
PICU需要熟悉22q11.2缺失综合征,尤其是在这些免疫功能低下的患者中推荐使用辐照过的和巨细胞病毒血清学阴性的血液成分。在本报告的患者队列中,指南的遵循情况并不一致。这个问题的严重程度在PICU可能更为普遍,我们建议各单位审查其在这方面的做法。低钙血症可能在任何时候出现,在重症监护环境中需要定期检查血钙状态。入住PICU应提供邀请专科会诊和优化长期护理的机会。